Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Sterling Swift

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
capital markets, Capital Markets, corporate
Office
San Diego
Active in the record
2023 to 2026

Deal experience

Deal types
Capital Markets & IPODebt Capital MarketsM&A
Sectors
Consumer & RetailFinancial ServicesHealthcare & Life SciencesHospitality & LeisureReal Estate
Jurisdictions
NasdaqUnited States

Recent deals

16 announced deals in the record
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering 28 Sept 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 446m
Latham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO 10 Aug 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 150m Capital Markets
Latham & Watkins Represents Extra Space Storage in US$550 Million Senior Notes Offering 30 Jun 2026
Debt Capital Markets Real Estate Latham & Watkins LLP USD 550m corporate
Latham & Watkins Advises Boundless Bio on Merger With Serapha Bio 24 Jun 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 230m capital markets
Latham & Watkins Advises on SpyGlass Pharma’s US$150 Million Initial Public Offering 10 Feb 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 150m Capital Markets
Latham Advises on Arrowhead Pharmaceuticals Upsized Offerings of US$625 Million Convertible Senior Notes, and US$200 Million Common Stock and Pre-Funded Warrants 13 Jan 2026
Capital Markets & IPO Financial Services Latham & Watkins LLP USD 625m Capital Markets
Latham & Watkins Advises on Immunome’s US$400 Million Public Offering 18 Dec 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 400m Capital Markets
Latham & Watkins Advises on Halozyme Therapeutics’ Convertible Senior Notes Offerings Totaling US$1.3 Billion 8 Nov 2025
Capital Markets & IPO Financial Services Latham & Watkins LLP USD 1.30bn corporate
Latham & Watkins Advises on Immunome’s Upsized Public Offering of Common Stock 30 Jan 2025
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 150m capital markets
Latham & Watkins Advises on Arrowhead Pharmaceuticals’ US$450 Million Underwritten Offering of Common Stock 4 Jan 2024
Capital Markets & IPO Latham & Watkins LLP USD 450m
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when Sterling Swift is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 16 deals for Sterling Swift

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction